Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox Virus

3 Sept 2022

Abstract excerpt

Beginning in May 2022, a novel cluster of monkeypox virus infections was detected in humans. This virus has spread rapidly to non-endemic countries, sparking global concern. Specific vaccines based on the vaccinia virus (VACV) have demonstrated high efficacy against monkeypox viruses in the past and are considered an important outbreak control measure. Viruses observed in the current outbreak carry distinct...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesvirus Infections and Treatments
Share to Poxvirus research and outbreaks
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36146766
DOI: 10.3390/v14091960

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox VirusPMID 36146766Read ↗

Vaccinia virus vaccination is expected to elicit highly cross-reactive immunity to the 2022 monkeypox virusSemantic proximity Read ↗

Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic developmentSemantic proximity Read ↗

Monkeypox Virus and Vaccinia Vaccines: Genomic and Antigenic Differences Relevant to Outbreaks and VaccinologySemantic proximity Read ↗

Multi-Epitope Vaccine for Monkeypox Using Pan-Genome and Reverse Vaccinology ApproachesSemantic proximity Read ↗

Comprehensive Profiling of Monkeypox Virus Antigens Identifies Potent Targets for Next-Generation mRNA Vaccine DevelopmentSemantic proximity Read ↗

In-silico formulation of a next-generation polyvalent vaccine against multiple strains of monkeypox virus and other related poxvirusesSemantic proximity Read ↗

Vaccine Approach for Human Monkeypox over the Years and Current Recommendations to Prevent the Outbreak: A Rapid ReviewSemantic proximity Read ↗

Novel Multi Epitope-based Vaccine against Monkeypox Virus: Vaccinomic approachSemantic proximity Read ↗

Vaccine approach for human monkeypox over the years and current recommendations to prevent the outbreak: a rapid reviewSemantic proximity Read ↗

Serological methods for the detection of antibodies against Monkeypox virus applicable for laboratories with different biosafety levelsSemantic proximity Read ↗

Novel Multi-Epitope Vaccine candidate derived from critically important proteins of Monkeypox isolatesSemantic proximity Read ↗

The impact of antigenic distance on Orthopoxvirus Vaccination and Mpox Infection for cross-protective immunitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.